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a b s t r a c t
The NS1 protein of inﬂuenza viruses is a major virulence factor and exerts its function through
interacting with viral/cellular RNAs and proteins. In this study, we identiﬁed heterogeneous nuclear
ribonucleoprotein A2/B1 (hnRNP A2/B1) as an interacting partner of NS1 proteins by a proteomic
method. Knockdown of hnRNP A2/B1 by small interfering RNA (siRNA) resulted in higher levels of NS
vRNA, NS1 mRNA, and NS1 protein in the virus-infected cells. In addition, we demonstrated that hnRNP
A2/B1 proteins are associated with NS1 and NS2 mRNAs and that knockdown of hnRNP A2/B1 promotes
transport of NS1 mRNA from the nucleus to the cytoplasm in the infected cells. Lastly, we showed that
knockdown of hnRNP A2/B1 leads to enhanced virus replication. Our results suggest that hnRNP A2/B1
plays an inhibitory role in the replication of inﬂuenza A virus in host cells potentially through
suppressing NS1 RNA/protein levels and NS1 mRNA nucleocytoplasmic translocation.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Inﬂuenza A viruses belong to the family Orthomyxoviridae and
harbor an eight segmented, single-stranded, and negative-sense
RNA genome, which codes for 11 viral proteins (Hale et al., 2008).
Different from most other RNA viruses, inﬂuenza viruses replicate
in the nucleus of the infected cells (Herz et al., 1981). In the
nucleus, the negative-sense virion RNAs (vRNAs) from the input
viruses are ﬁrst transcribed into 5′-capped and 3′-polyadenylated
viral mRNAs, which in turn are exported to the cytoplasm where
they are translated into viral proteins. Upon import of the viral
proteins into the nucleus, vRNAs are synthesized into full-length
complementary RNAs (cRNAs), which in turn serve as templates
for the synthesis of more vRNAs. The resulting vRNAs are either
used as templates for producing more viral mRNAs or encapsi-
dated into ribonucleoprotein structures to be exported to the
cytoplasm for virion assembly at the plasma membrane (Amorim
et al., 2011).
Inﬂuenza viral genome segment 8 codes for NS1 protein from
unspliced primary mRNA and NS2 protein from spliced mRNA
(Lamb and Lai, 1980; Robb et al., 2010). The NS1 protein is localized
in both the cytoplasm and nucleus and plays multiple roles in viral
replication cycle (Hale et al., 2008; Li et al., 1998). In the cytoplasm
of infected cells, NS1 antagonizes host interferon (IFN) system
through targeting protein kinase R (PKR) (Min et al., 2007; Wang
et al., 2000), IFN regulatory factor 3 (IRF-3) (Mibayashi et al.,
2007), and potentially also IKKγ (Wang et al., 2012). In the nucleus,
NS1 inhibits pre-mRNA splicing and mRNA nuclear export through
targeting a 30-kDa subunit of the cleavage and polyadenylation
speciﬁcity factor (CPSF) (Das et al., 2008; Krug et al., 2003;
Nemeroff et al., 1998), poly (A)-binding protein II (PABII) (Chen
et al., 1999), and/or components of the mRNA export machinery
(Satterly et al., 2007).
After being transcribed, cellular pre-mRNAs are known to
associate with nuclear proteins to form heterogeneous nuclear
ribonucleoprotein (hnRNP) complexes, which function to affect
the structure or nucleocytoplasmic transport of mRNAs (Dreyfuss
et al., 1993). The hnRNP family includes approximately 20 proteins,
ranging from hnRNPs A1 to U, and each hnRNP protein contains
RNA binding motifs and auxiliary domains for protein–protein or
protein–nucleic acid interactions (Krecic and Swanson, 1999;
Pinolroma et al., 1988). Multiple inﬂuenza viral proteins have been
reported to interact with different hnRNP members, such as
hnRNP M, H1 (Jorba et al., 2008), and A1 (Mayer et al., 2007),
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and the hnRNP family members have been shown to modulate
inﬂuenza viral replication cycle in virus-infected cells (Ufer, 2012).
Like other viruses, inﬂuenza viruses depend on host cellular
components, proteins in particular, to complete most (if not all)
steps in the viral replication cycle, including viral gene replication/
transcription/translation, intracellular trafﬁcking, and virion
assembly. This kind of dependence and the intracellular warfare
between inﬂuenza viruses and host cells create a vast plethora of
interactions between viral components and host cellular compo-
nents in virus-infected cells. Identiﬁcation of the host cellular
factors that play critical roles in viral replication cycle may provide
valuable information for designing novel antiviral therapy. In this
study, through a two-dimensional gel electrophoresis (2-DE)-
based proteomic method, we identiﬁed hnRNP A2/B1 as an
interacting partner of the inﬂuenza viral protein NS1 and found
that hnRNP A2/B1 suppresses NS1 RNA/protein levels and NS1
mRNA nucleocytoplasmic export.
Results
Identiﬁcation of hnRNP A2/B1 as an inﬂuenza virus NS1
interacting protein
We used a 2-DE-based proteomic method to identify the
proteins that are associated with inﬂuenza viral protein NS1
(Zhou et al., 2012a). Two populations of 293T cells were transi-
ently transfected with plasmids that express Flag alone (control)
and Flag-NS1, respectively. After afﬁnity puriﬁcation of the whole
cell lysates from the two populations of cells, the bound proteins
eluted from the afﬁnity beads were fractionated with two identical
2-DE gels. The protein spots uniquely appearing in the gel that
resolved the proteins puriﬁed from the cells that expressed Flag-
NS1 were excised, in-gel digested, and the resulting peptides
analyzed by mass spectrometry (MS). One of the proteins that
were identiﬁed by MS was hnRNP A2/B1, which is produced by
alternative splicing from a single gene and has been shown to play
important roles in RNA processing like RNA transport, translation,
splicing, and trafﬁcking (Kamma et al., 1999). hnRNP A2/B1 was
identiﬁed with high conﬁdence by MS with 18 unique peptides to
the proteins and a 58% sequence coverage (Supplementary Fig. S1).
Several other proteins were also identiﬁed to interact with NS1,
and those proteins will be reported in a separate paper.
Validation of the interaction between hnRNP A2/B1 and NS1 by
co-immunoprecipitation (co-IP) and mammalian two-hybrid analysis
We used co-IPs to validate the interaction between NS1 and
hnRNP A2/B1. As shown in Fig. 1A, immobilized anti-Flag anti-
bodies precipitated more HA-hnRNP A2/B1 from the cells
co-transfected with the plasmids that express Flag-NS1 and
HA-hnRNP A2/B1 than from the cells co-transfected with the
plasmids that express Flag alone and HA-hnRNP A2/B1 (top panel).
Similarly, in a reciprocal IP, immobilized anti-HA antibodies pre-
cipitated a larger amount of Flag-NS1 from the cells co-transfected
with the plasmids that express Flag-NS1 and HA-hnRNP A2/B1
than from the cells co-transfected with the plasmids that express
HA tag alone and Flag-NS1 (bottom panel). These results strongly
suggest that NS1 is speciﬁcally associated with hnRNP A2/B1.
hnRNP A2/B1 is an RNA binding protein (Han et al., 2010).
In order to test whether the NS1-hnRNP A2/B1 interaction is
mediated by RNAs, we used RNase (Sigma) to treat the cell lysates
before the IPs. The results demonstrated that the RNase treatment
did not change the association of NS1 with hnRNP A2/B1 in the
reciprocal co-IPs (data not shown), suggesting the interaction
between NS1 and hnRNP A2/B1 is not mediated by RNAs.
To further test whether NS1 and hnRNP A2/B1 interact in vivo in
cells, we performed a mammalian two-hybrid analysis. In this
assay, the interaction between hnRNP A2/B1 and NS1 brings the
association of Gal4 DNA-binding domain (BD) and activation
domain (AD), which in turn initiates the transcription of a reporter
gene GFP (Du et al., 2006). Co-transfection of 293T cells with the
Gal4 GFP reporter plasmid and the constructs encoding fusion
proteins of BD-NS1 and AD-hnRNP A2/B1 resulted in higher
expression of GFP than the negative control, in which BD and AD
were fused with two proteins that are known to not interact
(Fig. 1B; compare the right lane with the middle lane). As
expected, when BD and AD were fused with estrogen receptor α
and calmodulin, two known interacting proteins (Li and Sacks,
2007; Li et al., 2001; Zhou et al., 2012a) respectively, the co-
transfection resulted in strong expression of GFP (Fig. 1B; left
lane). In short, the results in this section suggest that NS1 interacts
with hnRNP A2/B1 in human cells in vivo.
hnRNP A2/B1 colocalizes with NS1 in human lung A549 cells
We then performed immunostaining and confocal microscopy
analysis using human lung A549 cells to determine whether NS1
and hnRNP A2/B1 physically colocalize in cells (Fig. 2). A549 cells
were infected with A/PR/8/34 viruses at a multiplicity of infection
(MOI) of 2 and ﬁxed at 2 h postinfection (hpi), followed by
incubation with anti-NS1 and anti-hnRNP A2/B1 antibodies,
appropriate ﬂuorescence-labeled secondary antibodies, and 4′,6-
diamidino-2-phenylindole (DAPI). Confocal microscopy analysis of
Fig. 1. Validation of the interaction between hnRNP A2/B1 and NS1: (A) co-IPs: Cell
lysates from the cells expressing Flag-NS1 and HA-hnRNP A2/B1, or the cells
expressing Flag alone and HA-hnRNP A2/B1 (control), were immunoprecipitated
with anti-Flag M2 resin, and the immunoprecipitated proteins were probed with
anti-HA antibody in Western blotting. In a reciprocal co-IP, cell lysates from the
cells expressing Flag-NS1 and HA-hnRNP A2/B1, or the cells expressing HA alone
and Flag-NS1 (control), were precipitated with immobilized anti-HA antibody, and
the immunoprecipitated proteins were probed with anti-Flag antibody in Western
blotting. (B) Mammalian two-hybrid analysis: 293T cells were co-transfected with
plasmids expressing BD-NS1, AD-hnRNP A2/B1, and a Gal4 GFP reporter, and the
induction of reporter GFP expression was detected by Western blotting with an
anti-GFP antibody. The positive and negative controls were performed by co-
transfection of 293T cells with Gal4 GFP reporter plasmid and the plasmids in
which the BD and AD were fused with two proteins that are known to interact and
not interact, respectively.
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the stained cells demonstrated that hnRNP A2/B1 protein was
predominantly located in the nucleus; while a small portion of
NS1 protein in the infected cells was located in the cytoplasm, the
majority of it was located in the nucleus at 2 hpi, which was also
observed by other research groups (Li et al., 1998; Wolff et al.,
1998). The merging of the hnRNP A2/B1- and NS1-stained images
suggests that hnRNP A2/B1 and NS1 colocalize in the nucleus of
the infected cells at 2 hpi (Fig. 2).
hnRNP A2/B1 suppresses NS1 protein levels in the virus-infected cells
To determine the potential roles of the interaction between
hnRNP A2/B1 and NS1, we silenced the expression of endogenous
hnRNP A2/B1 by small interfering RNA (siRNA) in A549 cells and
then examined the effect of the silencing on NS1 protein levels in
the virus-infected cells. The results demonstrated that when the
expression of hnRNP A2/B1 was silenced by siRNAs (Fig. 3; top
panel), viral NS1 protein levels in the virus-infected cells increased
(Fig. 3; middle panel), suggesting that endogenous hnRNP A2/B1
suppresses NS1 protein levels in the virus-infected cells. It is
interesting to note that knockdown of hnRNP A1, which is highly
homologous to and shares some functions with hnRNP A2/B1 (Han
et al., 2010; Lin et al., 2009), does not affect NS1 protein levels in
the inﬂuenza A virus-infected cells (Read and Digard, 2010),
implying that the effect of hnRNP A2/B1 on NS1 protein levels in
the virus-infected cells may be unique.
hnRNP A2/B1 inhibits the levels of NS vRNA and NS1 mRNA
in the virus-infected cells
To elucidate the potential mechanism by which hnRNP A2/B1
suppresses viral NS1 protein levels in the virus-infected cells, we
examined the effect of knockdown of hnRNP A2/B1 expression on
NS vRNA and NS1 mRNA levels in the virus-infected A549 cells
using quantitative real-time PCR (qRT-PCR). Both NS vRNA
(Fig. 4A) and NS1 mRNA (Fig. 4B) levels increased signiﬁcantly
(pr0.05) in the transfected and infected A549 cells when the
endogenous hnRNP A2/B1 was knocked down by siRNA. These
results suggest that endogenous hnRNP A2/B1 suppresses both NS
vRNA and NS1 mRNA levels in the infected cells.
hnRNP A2/B1 binds to NS1 and NS2 mRNAs, and does not affect NS1
mRNA splicing but inhibits NS1 mRNA nuclear export
hnRNP proteins are known to regulate splicing (Caputi et al.,
1999; Han et al., 2010) and nuclear export of mRNAs (Reed and
Hurt, 2002; Schneider and Wolff, 2009). Thus, we tested whether
hnRNP A2/B1 plays a role in regulating the splicing and nuclear
export of NS1 mRNA in the virus-infected cells. For this purpose,
we ﬁrst examined whether hnRNP A2/B1 proteins are associated
Fig. 2. Colocalization of hnRNP A2/B1 with NS1 in the nucleus of the virus-infected cells. A549 cells were infected with A/PR/8/34 viruses at an MOI of 2 and stained with
DAPI and antibodies directed against hnRNP A2/B1 and NS1 at 2 hpi. The images were acquired by using a confocal laser-scanning microscope. A merged image of the hnRNP
A2/B1-staining (in red) and NS1-staining (in green) shows the overlap of hnRNP A2/B1 and NS1 in the nucleus of the infected cells.
Fig. 3. Silencing of endogenous hnRNP A2/B1 results in increases in NS1 proteins in
the virus-infected cells. A549 cells were transfected with a randomized siRNA
sequence (control) or a siRNA sequence targeting hnRNP A2/B1. Forty-eight hours
after the transfection, the cells were infected with A/PR/8/34 viruses at an MOI of
0.5 and harvested at the indicated times for examination of the expression of NS1
and hnRNP A2/B1 by Western blotting. Actin was used as a loading control.
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with NS1 or NS2 mRNAs using RNA immunoprecipitation (RNA-
IP). 293T cells were transfected with the plasmids that express HA-
hnRNP A2/B1 or HA tag alone for control, and then infected with
A/PR/8/34 viruses at an MOI of 3. Ten hours after the infection, the
cells were harvested for IPs with immobilized anti-HA antibodies
to pulldown the complexes that were associated with hnRNP
A2/B1. After the IPs, proteinase K was used to release the hnRNP
A2/B1-associated RNAs from the precipitated complexes, followed
by reverse-transcription of mRNAs with the oligo (dT) primer,
which left vRNA and cRNA unaffected (Robb et al., 2010), and PCR
ampliﬁcation of the reverse-transcribed cDNAs. Because the pri-
mers we used in the PCR ampliﬁcation were speciﬁc for the cDNAs
of both NS1 and NS2 mRNAs (Fig. 5A), the amounts (or presence/
absence) of both NS1 and NS2 mRNAs in the precipitated com-
plexes could be detected. As shown in Fig. 5B, transfection of the
cells with the plasmid that expresses HA-hnRNP A2/B1 did not
affect the transcription of either NS1 or NS2 (Fig. 5B, left panel).
The immobilized anti-HA antibody precipitated substantially more
NS1 and NS2 mRNAs from the cells that express HA-hnRNP A2/B1
than from the control cells (Fig. 5B, right panel), suggesting that
both NS1 and NS2 mRNAs are speciﬁcally associated with hnRNP
A2/B1 proteins in the infected cells.
After conﬁrming that NS1 and NS2 mRNAs are associated with
hnRNP A2/B1 proteins in the virus-infected cells (Fig. 5),
we examined whether hnRNP A2/B1 affects NS1 pre-mRNA splicing.
To test this possibility, we compared the ratios of NS2 to NS1 mRNAs
in the infected cells with a normal level of endogenous hnRNP A2/B1
to those in the cells with a depleted hnRNP A2/B1 using reverse
transcriptions as described above. The results demonstrated that
knockdown of hnRNP A2/B1 by siRNAs does not affect NS1 and NS2
mRNA splicing in infected A549 cells (data not shown).
We then examined the potential role of hnRNP A2/B1 in
nucleocytoplasmic translocation of NS1 mRNAs. We used a
differential-centrifugation-based method (Wang et al., 2006) to
fractionate cell lysate into cytoplasmic and nuclear parts. Western
blot analysis using marker proteins of the cytoplasm and nucleus
demonstrated that there were no noticeable cross-contaminations
in our cytoplasmic and nuclear fractionations (Fig. 6A).
We transfected the A549 cells with the siRNAs oligos targeting
hnRNP A2/B1 or a randomized siRNA sequence for control and
infected the transfected cells with A/PR/8/34 viruses. The trans-
fected and infected cells were harvested and fractionated, and NS1
mRNAs in the cytoplasmic and nuclear factions were quantiﬁed by
qRT-PCR. The results demonstrated that when hnRNP A2/B1
expression was silenced by siRNAs, the ratios of the cytosolic to
nuclear NS1 mRNAs at 6 and 10 hpi increased (Fig. 6B). These
results suggest that endogenous hnRNP A2/B1 inhibits the nuclear
export of viral NS1 mRNA in the infected cells.
hnRNP A2/B1 inhibits inﬂuenza virus replication, but virus infection
does not affect hnRNP A2/B1 levels in the infected cells
Because hnRNP A2/B1 suppresses inﬂuenza NS vRNA, NS1
mRNA, and NS1 protein levels (Figs. 3 and 4), and inhibits NS1
mRNA nuclear export (Fig. 6) in the virus-infected cells, we
speculated that hnRNP A2/B1 may affect virus replication.
We infected the hnRNP A2/B1-silenced A549 cells with A/PR/8/34
viruses at two different MOIs and harvested the viruses for titer
Fig. 4. hnRNP A2/B1 suppresses the levels of NS vRNA and NS1 mRNA in the virus-
infected cells. A549 cells were transfected with a randomized siRNA sequence
(control) or a siRNA sequence targeting hnRNP A2/B1. Forty-eight hours after the
transfection, the cells were infected with A/PR/8/34 viruses at an MOI of 0.5 and
harvested at 24 and 36 hpi for examination of NS vRNA (A) and NS1 mRNA (B) by
qRT-PCR. Values are the means7S.E. of three separate sample preparations.
nDenotes pr0.05.
Fig. 5. hnRNP A2/B1 proteins are associated with NS1 and NS2 mRNAs:
(A) schematic representation of NS1 mRNA, NS2 pre-mRNA and the positions of
the primers used to amplify NS1 and NS2 mRNAs. The coding regions of NS1 and
NS2 mRNAs are shown as white and hatched boxes, respectively. The numbers
above the coding regions indicate the start and end nucleotide positions in the NS1
and NS2 mRNAs. The NS2 mRNA is alternatively spliced from NS1 mRNA, and the
V-shaped line denotes the region that is removed in splicing. With the primers
(black bar) indicated in the diagram, the amplicon size for NS1 and NS2 was
calculated to be 693 and 221 bps, respectively. (B) hnRNP A2/B1 proteins are
associated with NS1 and NS2 mRNAs. 293T cells transiently transfected with the
plasmids that express HA-hnRNP A2/B1 or HA tag alone (control) were infected
with A/PR/8/34 viruses at an MOI of 3. At 10 hpi, the cells were harvested and lysed,
and the resulting whole cell lysates were immunoprecipitated with immobilized
anti-HA antibody. The RNAs immunoprecipitated were released from the com-
plexes by incubating with proteinase K, reverse-transcribed, and PCR-ampliﬁed
with the primers indicated in (A). The resulting DNAs were examined by a 1.3%
agarose gel. GAPDH was used as an internal reference.
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determination at two different time frames. In both cases, when the
expression of hnRNP A2/B1 was silenced, the virus titers increased
(Fig. 7) (po0.05 for all time points except for 48 hpi in Fig. 7A, at
which p¼0.077). These results suggest that endogenous hnRNP A2/
B1 inhibits inﬂuenza virus replication in the infected cells.
We also tested whether inﬂuenza virus infection would affect
the levels of endogenous hnRNP A2/B1 proteins in the virus-
infected cells. The results demonstrated that when A549 cells were
infected with A/PR/8/34 viruses at an MOI of 0.3 for 24 h, cellular
hnRNP A2/B1 protein levels in the infected cells were not changed
by virus infection (data not shown).
Discussion
Although the NS1 protein is not part of the inﬂuenza virion, it is
expressed at high levels in the virus-infected cells (Lazarowitz
et al., 1971; Liu et al., 2012). NS1 is a multi-functional protein (Hale
et al., 2008). One major function of NS1 is to inhibit host immune
responses through suppressing the induction of type I-IFNs and
IFN-mediated proteins (Billharz et al., 2009; Geiss et al., 2002;
Krug et al., 2003; Tisoncik et al., 2011). In addition to its role in
inhibiting host immune responses, NS1 also plays important roles
in other aspects in the virus-infected cells (Hale et al., 2008). For
example, NS1 has been shown to affect mRNA splicing and nuclear
export (Garaigorta and Ortin, 2007), protein synthesis (de la Luna
et al., 1995; Enami et al., 1994), and cell apoptosis (Ehrhardt et al.,
2007). Most, if not all, of the reported functions of NS1 are realized
through the physical interactions of NS1 proteins with cellular/
viral proteins or RNAs (Hale et al., 2008). In the present study,
through a 2-DE-based proteomic approach, we found that NS1 is
associated with hnRNP A2/B1, a member of a large family of proteins
that are highly divergent in structure and function (Han et al., 2010;
Shyu and Wilkinson, 2000). hnRNP A2 and B1 proteins are produced
by alternative splicing of a single gene with the difference of a 12-
amino-acid insertion in N-terminal RNA-binding motif in B1 (Burd
et al., 1989; Kozu et al., 1995) and have been shown to regulate RNA
alternative splicing (Bilodeau et al., 2001; Mayeda et al., 1994), RNA
trafﬁcking (Munro et al., 1999; Pinol-Roma and Dreyfuss, 1992; Shan
et al., 2003), and telomere maintenance (Ford et al., 2002).
Most cellular mRNAs are transported from the nucleus to the
cytoplasm through the mRNA export receptors Tap/NXF1 that
interact with both mRNAs and components of the nuclear pore
complex to direct mRNAs through the nuclear pore complex (Stutz
and Izaurralde, 2003). The interaction between mRNA and Tap/
NXF1 is mediated by adapter proteins such as Aly (Strasser and
Hurt, 2000; Stutz et al., 2000), which is recruited to the mRNA
during splicing by export factor UAP56 (Luo et al., 2001). Several
lines of evidence suggest that viral mRNA nuclear export in the
virus-infected cells is also mediated by the Tap/NXF1 export
pathway (Hao et al., 2008; Read and Digard, 2010; Wang et al.,
2008), and viruses have evolved strategies to introduce viral
mRNAs into the Tap/NXF1 export system through recruiting
cellular export factors, such as export factors Aly and UAP56
(Chen et al., 2005; Koffa et al., 2001; Lischka et al., 2006). In the
case of inﬂuenza viral mRNA nuclear export, it seems that NS1
proteins play an important role in directing viral mRNAs into the
nuclear mRNA export machinery via recruiting essential export
factors (Schneider and Wolff, 2009). In support of this notion, it
has been shown that NS1 proteins from inﬂuenza A and B viruses
interact with mRNA export factors Tap/NXF1 and UAP56,
Fig. 6. hnRNP A2/B1 inhibits NS1 mRNA nuclear export: (A) cytoplasmic and
nuclear fractionation. A549 cells transfected with a randomized siRNA sequence
(control) or a siRNA sequence targeting hnRNP A2/B1 were lysed and fractionated
into nuclear and cytoplasmic parts, and the purity of each part was examined by
Western blotting using antibodies against the nuclear and cytoplasmic markers
(histone H2B and tubulin, respectively). (B) hnRNP A2/B1 inhibits NS1 mRNA
nucleocytoplasmic translocation. A549 cells transfected with a randomized siRNA
sequence (control) or a siRNA sequence targeting hnRNP A2/B1 were infected with
A/PR/8/34 viruses at an MOI of 1. The cells were harvested at the indicated times
and fractionated into the nuclear and cytoplasmic parts, and the NS1 mRNA in each
part was quantiﬁed by qRT-PCR. 18s-rRNA was used as an internal control. Values
are the means7S.E. of three separate sample preparations. nDenotes pr0.05.
Fig. 7. Silencing of endogenous hnRNP A2/B1 enhances virus replication. A549 cells
were transfected with a randomized siRNA sequence (control) or a siRNA sequence
targeting hnRNP A2/B1. Forty-eight hours after the transfection, the cells were
infected with A/PR/8/34 viruses at an MOI of 0.5 (A) or 1 (B). The supernatants were
harvested at the indicated times for examinations of virus titers. Values are the
means7S.E. of three separate sample preparations. nDenotes pr0.05.
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respectively (Satterly et al., 2007; Schneider et al., 2009), to
facilitate nuclear export of viral mRNAs (Schneider and Wolff,
2009). In the present study, we found that nuclear protein hnRNP
A2/B1 interacts with both NS1 protein (Fig. 1) and NS1 mRNA
(Fig. 5) and inhibits the nuclear export of NS1 mRNA in the
inﬂuenza virus-infected cells (Fig. 6). A potential mechanism
underlying the inhibitory effect of hnRNP A2/B1 on viral NS1
mRNA nuclear export is that the interaction of hnRNP A2/B1 with
NS1 protein interferes with NS1 protein’s ability to recruit mRNA
export factors such as Tap/NXF1 or other factors to the NS1 mRNAs
(Satterly et al., 2007; Schneider and Wolff, 2009). It has been
shown that inﬂuenza viral NS1 protein is associated with inﬂuenza
viral mRNAs of NA, M1, and PB1 genes (Wang et al., 2008). If the
hypothesis described above is correct, it is highly likely that hnRNP
A2/B1 may also play an important role in regulating the nuclear
export of other inﬂuenza viral mRNAs including (but not limited
to) those of NA, M1, and PB1 (Wang et al., 2008).
We also found in the present study that knockdown of hnRNP
A2/B1 expression by siRNA resulted in higher levels of NS vRNA,
NS1 mRNA (Fig. 4), and NS1 protein (Fig. 3), suggesting that
endogenous hnRNP A2/B1 suppresses NS vRNA, NS1 mRNA, and
NS1 protein in the virus-infected cells. Because the viral mRNAs
exported from the nucleus are translated into viral proteins in the
cytoplasm and some of the resulting viral proteins are transported
back to the nucleus to facilitate further ampliﬁcation of vRNAs and
viral mRNAs, it is likely that the observed increases in NS vRNA,
NS1 mRNA, and NS1 protein (Figs. 3 and 4) were a consequence of
the increased nuclear export of NS1 mRNA (Fig. 6) when the
expression of hnRNP A2/B1 was silenced. Alternatively, it is also
possible that the NS1-hnRNP A2/B1 complex directly inhibits the
catalytic activity of viral polymerase, which is responsible for
replicating and transcribing viral RNAs, and/or the host RNA
polymerase II, which has been shown to affect viral mRNA
transcription and viral mRNA nuclear export (Amorim et al.,
2007). Furthermore, because hnRNPs, including hnRNP A2/B1, play
important roles in regulating protein translation (Lin et al., 2009;
Sinnamon and Czaplinski, 2011; Svitkin et al., 1996), it is possible
that hnRNP A2/B1 may affect NS1 protein expression through
regulating protein translation process. For example, knockdown of
hnRNP A2/B1 could lead the virus-infected cells to synthesize NS1
protein at the expense of NS2 production.
The results from the present study revealed a novel role of hnRNP
A2/B1 in regulating inﬂuenza viral NS1 gene products (proteins and
RNAs), major factors that determine the inﬂuenza virus virulence and
also contribute to the pathogenesis of the viruses. At the same time,
our results also raised several questions that need to be addressed in
the future. First, our results suggest that hnRNP A2/B1 suppresses NS
vRNA and NS1 mRNA levels (Fig. 4) potentially through inhibiting NS
gene replication/transcription, or through inhibiting NS1 mRNA
nuclear export (Fig. 6). Viral gene replication/transcription and viral
mRNA nuclear export are two molecular processes that are closely
related to each other in the virus-infected cells. It is not clear at the
present time whether hnRNP A2/B1 independently inhibits these
two molecular processes or if hnRNP A2/B1 affects one of them and
the other is a secondary change. Second, we have shown in the
present study that NS1 proteins and NS1/NS2 mRNAs are associated
with hnRNP A2/B1 proteins. It remains to be determined whether
these kinds of functional associations with hnRNP A2/B1 proteins are
speciﬁc to NS gene products or also apply to other viral gene products
or even some cellular gene products. Third, the molecular mechan-
ism underlying the inhibitory effect of hnRNP A2/B1 on NS1 [and
potentially other viral genes (Wang et al., 2008)] mRNA nuclear
export in the virus-infected cells requires further investigation.
Together with the information obtained in the present study, these
results should provide a clear picture of how hnRNP A2/B1 regulates
inﬂuenza viral gene expression and virus replication in host cells.
Materials and methods
Cell culture and virus infection
Human embryonic kidney (HEK) 293T cells, human lung
epithelial A549 cells, and Madin–Darby canine kidney (MDCK)
cells (ATCC, Manassas, VA) were cultivated in Dulbecco modiﬁed
Eagle medium (DMEM; Hyclone Laboratories, Logan, UT) supple-
mented with 10% fetal bovine serum (FBS; Atlanta Biologicals,
Lawrenceville, GA) and 1% penicillin and streptomycin. Inﬂuenza
A/PR/8/34H1N1 viruses (ATCC) were propagated and titrated in
MDCK cells as described previously (Wang et al., 2012).
Plasmid construction and cell transfection
Flag tagged NS1 gene and Flag alone were cloned into
pcDNA3.1 as described previously (Wang et al., 2012). For mam-
malian two-hybrid assay, NS1 and hnRNP A2/B1 cDNAs (GenBank
accession no: NM_031243) were inserted into EcoR I and Sal I sites
of pM vector with GAL4 BD and pVP16 vector with AD (BD
Biosciences, San Jose, CA), respectively. hnRNP A2/B1 gene was
also cloned into pCruz HA vector (Santa Cruz, Santa Cruz, CA) by
inserting the cDNA into the Not I and Bgl II sites of the vector. All
expression plasmids were veriﬁed by DNA sequencing. Cell trans-
fection was performed as described previously (Wang et al., 2012).
Afﬁnity puriﬁcation and 2-DE
Human 293T cells transiently transfected with plasmids
expressing Flag alone or Flag-NS1 (approximately 1109 each)
were harvested and washed twice with cold phosphate-buffered
saline (PBS) 48 h after the transfection. The cells were lysed in
5 packed cell pellet volumes of a lysis buffer (10 mM Tris–HCl pH
7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 10 mM NaF, 10 mM
β-glycerophosphate, and 1 mM Na3VO4) supplemented with pro-
tease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN) by
douncing with a glass dounce homogenizer (Kontes Glass Co.,
Vineland, NJ). After centrifugation at 20,000g for 15 min at 4 1C,
the pellets were further extracted once with the lysis buffer and
sonication. The combined supernatants from the cells that express
Flag-NS1 or the control cells that express Flag alone were incu-
bated separately with 200 μl pre-washed anti-Flag M2 resin
(Sigma, St. Louis, MO) for 5 h at 4 1C. After washing (41 ml),
the bound proteins were eluted with an elution buffer containing
50 mM Tris–HCl pH 7.5, 0.5 M NaCl, and 250 mM Flag peptide
(Sigma), and then concentrated by trichloroacetic acid precipita-
tion. The precipitated proteins from the two groups of cells were
separately fractionated by two identical 2-DE gels, as described
previously (Zhou et al., 2012a).
MS analysis and database search
After 2-DE fractionations, the two 2-DE gels that resolved the
afﬁnity-puriﬁed proteins from the cells that express Flag alone
(control) or the cells that express Flag-NS1 were visually
inspected. The protein spots uniquely appearing in the gel that
resolved the proteins puriﬁed from the cells that express Flag-NS1
(but not in the control gel) were excised, in-gel digested, and the
resulting peptides analyzed by MS. In-gel digestion, MS analysis,
and database search were carried out as described previously
(Wang et al., 2012).
Mammalian two-hybrid analysis
Mammalian two-hybrid analysis of protein–protein interactions
was performed according to our previous protocol (Du et al., 2006;
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Wang et al., 2005). Brieﬂy, the coding sequences of NS1 and hnRNP
A2/B1 were inserted into the vectors encoding BD and AD, respec-
tively, and the two constructs were co-transfected into the 293T cells
with a Gal4 GFP reporter plasmid (2 μg of each plasmid in a 60-mm
plate). The positive and negative controls were performed by co-
transfection of the 293T cells with Gal4 GFP reporter plasmid and the
two expression vectors in which the BD and AD were fused with two
proteins that are known to interact (estrogen receptor α and
calmodulin (Li and Sacks, 2007; Li et al., 2001; Zhou et al., 2012a))
and not interact, respectively. The expression of GFP was detected by
Western blotting using an anti-GFP antibody.
co-IP
Vectors expressing HA-hnRNP A2/B1 or Flag-NS1 were co-
transfected into 293T cells (1108 cells). For control, the vector
expressing Flag alone was used to replace the vector that
expresses Flag-NS1 in the co-transfection. Forty-eight hours after
the transfection, cells were lysed and immunoprecipitated with
anti-Flag M2 resin as described above. The NS1-associated pro-
teins were detected by Western blotting using an anti-HA anti-
body (Santa Cruz). In a reciprocal co-IP, cell transfection, IP, and
Western blotting were performed as described above except that
(1) for control, the vector expressing HA alone was used to replace
the vector that expresses HA-hnRNP A2/B1 in the co-transfection;
(2) the IP was performed using immobilized anti-HA antibody
(Santa Cruz); (3) the hnRNP A2/B1-associated proteins were
detected by Western blotting using an anti-Flag antibody (Sigma).
Immunoﬂuorescence staining and confocal microscopy
The immunoﬂuorescence staining and image acquisition were
performed as described in our previous papers (Zhou et al., 2012a,
2012b). Speciﬁcally, A549 cells at 90% conﬂuency on a coverslip
were infected with A/PR/8/34 viruses at an MOI of 2. At 2 hpi, cells
were washed with PBS, ﬁxed by 3.7% formaldehyde in PBS for
15 min, and permeabilized by 0.2% Triton X-100 in PBS for 10 min.
The cells were then washed and blocked with 10% normal horse
serum in PBS for 1 h, followed by incubation with mouse anti-NS1
antibody (1:1000) in 5% normal horse serum in PBS overnight at
4 1C. After washing, the cells were incubated with DyLight 488
horse anti-mouse IgG antibody (Vector Labs, Burlingame, CA) for
1 h at room temperature. The cells were then washed, blocked
with 10% normal goat serum, and incubated with rabbit anti-
hnRNP A2/B1 antibody (1:2500), followed by incubation with
Texas Red goat anti-rabbit IgG antibody (Vector Labs) and DAPI.
The images were acquired by a NIKON Eclipse 90i confocal
ﬂuorescence microscope (Nikon, Tokyo, Japan).
RNA interference (RNAi)
Three siRNA oligos speciﬁcally targeting hnRNP A2/B1
[5′-AAGCUUUGAAACCACAGAAGA-3′ (Patry et al., 2003), 5′-AAA-
GAUCAAGAGGAUUUGGUU-3′ and 5′-GGAACAGUUCCGUAAGCUC-3′
(Iwanaga et al., 2005)] were co-transfected into A549 cells using
Lipofectamine RNAiMAX (Invitrogen, Carlsbad, CA) as described
previously (Wang et al., 2012).
qRT-PCR
The analysis was performed according to our previous protocol
(Liu et al., 2012; Wang et al., 2012) with the following speciﬁca-
tions. A549 cells treated with siRNAs oligos targeting hnRNP A2/B1
or nontargeting siRNAs (negative control) were infected with the
A/PR/8/34 viruses. The cells were harvested and total RNA was
extracted using an RNeasy Mini kit (Qiagen, Valencia, CA) at
appropriate hpi. vRNAs and mRNA were reverse-transcribed
(Improm-II Reverse Transcriptase kit; Promega, Madison, WI) with
the Uni-12 primer (Hoffmann et al., 2001) and the oligo (dT)
primer (Promega), respectively, and the resulting cDNAs were
ampliﬁed by qRT-PCR with the primers speciﬁc for the NS1 gene
(Forward: 5′-GACCGGCTGGAGACTCTAAT-3′ and reverse:
5′-CTGGAAGAGAAGGCAATGGT-3′). The relative levels of mRNAs
were determined using actin mRNA as an internal control and
calculated using the traditional 2ΔΔCt method (Livak and
Schmittgen, 2001). The relative levels of vRNA were determined
based on a standard curve generated by serial dilutions of the NS1
expression plasmids used in cell transfection (Shin et al., 2007).
RNA-IP
The vectors expressing HA-hnRNP A2/B1 or HA tag alone as
control were transiently transfected into 293T cells. Forty-eight
hours after the transfection, the cells were infected with A/PR/8/34
viruses at an MOI of 3. Ten hours after the infection, the cells were
harvested and lysed for IP with immobilized anti-HA antibody as
described above. The immunoprecipitated complexes were treated
with 150 μg/ml proteinase K for 90 min at 37 1C. After extraction
of the total RNA from the immunoprecipitated complexes, the
oligo (dT) primer was used to reverse-transcribe mRNAs into
cDNAs, and the following primers were then used to PCR-
amplify DNA (25 cycles) from the reverse-transcribed cDNAs:
NS1 primers (Forward: 5′-ATGGATCCAAACACTGTGTC-3′ and
reverse: 5′-TCAAACTTCTGACCTAATTGTTCC-3′); glyceraldehyde
3-phosphate dehydrogenase (GAPDH) primers (Forward: 5′-CG-
GAGTCAACGGATTTGGCC-3′ and reverse: 5′-GTGGCAGAGATGG-
CATGGAC-3′). The ampliﬁed DNAs were detected with a 1.3%
agarose gel and further conﬁrmed by DNA sequencing.
Subcellular fractionation
Nuclear and cytoplasmic fractionations were performed
according to a published protocol (Wang et al., 2006). Brieﬂy, cells
were harvested and swelled on ice in a hypertonic buffer (10 mM
Tris–HCl, pH 7.5, 10 mM NaCl, and 3 mM MgCl2) for 3 min,
followed by centrifugation at 1500g for 3 min. The cell pellet
was lysed in four packed cell pellet volumes of buffer A [10 mM
Tris–HCl, pH 7.5, 10 mM NaCl, 3 mM MgCl2, 10% (v/v) glycerol, 0.5%
(v/v) NP-40, 0.5 mM DTT, and 100 U/ml RNasin or 1 protease
inhibitor] by general pipetting. After centrifugation at 4500g for
3 min at 4 1C, supernatant was saved as cytoplasmic fraction. The
pellet was resuspended in buffer A supplemented with detergents
[3.3% (w/v) sodium deoxycholate and 6.6% (v/v) Tween 20] and
incubated on ice for 5 min. The insoluble materials were desig-
nated as nuclei and collected by centrifugation at 10,000g for
5 min and washed with buffer A once to remove residual cyto-
plasmic contamination. The integrity of the isolated nuclei was
examined by microscopy after staining with trypan blue. The total
RNAs were extracted from the cytoplasmic and nuclear fractions
and the isolated RNAs were treated with RNase-free DNase I
(Invitrogen) at room temperature for 15 min, followed by incuba-
tion at 37 1C for 30 min to remove genomic DNAs. Three micro-
grams of the resulting RNAs were reverse transcribed into cDNAs
as described above. 18S-rRNA was used as an internal control in
the qRT-PCR (Zhu and Altmann, 2005).
Plaque assay
Plaque assay was carried out as described previously (Wang
et al., 2012).
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Statistical analysis
Statistical analysis was performed using an independent-
sample t-test by Systat 13 (SPSS 13).
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